Terence Flynn
Stock Analyst at Morgan Stanley
(4.71)
# 747
Out of 4,792 analysts
1074
Total ratings
60.5%
Success rate
10.9%
Average return
Main Sectors:
Stocks Rated by Terence Flynn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Reiterated: Buy | $115 | $98.13 | +17.19% | 91 | Sep 8, 2026 | |
| ALMS Alumis | Reiterated: Buy | $39 → $29 | $9.80 | +195.92% | 11 | Sep 2, 2026 | |
| VRTX Vertex Pharmaceuticals | Initiated Coverage: Buy | $616 → $665 | $521.12 | +27.61% | 53 | Sep 1, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $165 | $145.65 | +13.29% | 63 | Aug 20, 2026 | |
| AMGN Amgen | Reiterated: Hold | $351 → $362 | $391.27 | -7.48% | 56 | Aug 19, 2026 | |
| MRK Merck & Co. | Upgraded: Buy | $116 → $179 | $147.53 | +21.33% | 56 | Aug 19, 2026 | |
| MRNA Moderna | Reiterated: Hold | $39 → $89 | $135.61 | -34.37% | 37 | Aug 19, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Sell | $40 | $64.41 | -37.90% | 50 | Aug 14, 2026 | |
| BHVN Biohaven | Reiterated: Buy | $18 → $19 | $15.00 | +26.67% | 19 | Aug 12, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $48 | $19.91 | +141.08% | 8 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $11 → $10 | $8.76 | +14.16% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $126 | $41.23 | +205.60% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 | $12.21 | +22.85% | 19 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.47 | - | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $22 → $23 | $28.49 | -19.27% | 16 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,347 → $1,419 | $1,124.21 | +26.22% | 80 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $64 → $65 | $60.59 | +7.28% | 30 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $516 → $515 | $506.82 | +1.61% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 | $27.78 | +0.79% | 60 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $278 → $296 | $250.91 | +17.97% | 54 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $294 | $267.08 | +10.08% | 58 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $730 → $758 | $807.65 | -6.15% | 60 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $222 → $231 | $210.73 | +9.62% | 62 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $38 | $26.26 | +44.71% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $13.67 | -34.16% | 28 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $32 → $33 | $53.45 | -38.26% | 13 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.44 | - | 11 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.77 | n/a | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $16 | $45.40 | n/a | 13 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $12 | $3.54 | n/a | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €90.25 | €132.15 | n/a | 1 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $41.51 | $8.50 | n/a | 1 | Dec 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $16 | $107.04 | n/a | 2 | Mar 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $163 → $155 | $258.00 | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $78.52 | n/a | 1 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $31 | $8.04 | n/a | 4 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $34.63 | n/a | 4 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $38 | $9.91 | n/a | 1 | Nov 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $36 | $5.28 | n/a | 1 | Jul 21, 2015 |
BioNTech SE
Sep 8, 2026
Reiterated: Buy
Price Target: $115
Current: $98.13
Upside: +17.19%
Alumis
Sep 2, 2026
Reiterated: Buy
Price Target: $39 → $29
Current: $9.80
Upside: +195.92%
Vertex Pharmaceuticals
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $616 → $665
Current: $521.12
Upside: +27.61%
Gilead Sciences
Aug 20, 2026
Reiterated: Buy
Price Target: $165
Current: $145.65
Upside: +13.29%
Amgen
Aug 19, 2026
Reiterated: Hold
Price Target: $351 → $362
Current: $391.27
Upside: -7.48%
Merck & Co.
Aug 19, 2026
Upgraded: Buy
Price Target: $116 → $179
Current: $147.53
Upside: +21.33%
Moderna
Aug 19, 2026
Reiterated: Hold
Price Target: $39 → $89
Current: $135.61
Upside: -34.37%
Bristol-Myers Squibb Company
Aug 14, 2026
Reiterated: Sell
Price Target: $40
Current: $64.41
Upside: -37.90%
Biohaven
Aug 12, 2026
Reiterated: Buy
Price Target: $18 → $19
Current: $15.00
Upside: +26.67%
Legend Biotech
Aug 12, 2026
Reiterated: Buy
Price Target: $48
Current: $19.91
Upside: +141.08%
Aug 10, 2026
Rated: Hold
Price Target: $11 → $10
Current: $8.76
Upside: +14.16%
Aug 10, 2026
Rated: Buy
Price Target: $126
Current: $41.23
Upside: +205.60%
Aug 10, 2026
Rated: Hold
Price Target: $15
Current: $12.21
Upside: +22.85%
Aug 10, 2026
Rated: Hold
Price Target: n/a
Current: $3.47
Upside: -
Aug 10, 2026
Rated: Hold
Price Target: $22 → $23
Current: $28.49
Upside: -19.27%
Aug 6, 2026
Reiterated: Buy
Price Target: $1,347 → $1,419
Current: $1,124.21
Upside: +26.22%
Aug 6, 2026
Rated: Buy
Price Target: $64 → $65
Current: $60.59
Upside: +7.28%
Aug 6, 2026
Rated: Hold
Price Target: $516 → $515
Current: $506.82
Upside: +1.61%
Aug 4, 2026
Reiterated: Hold
Price Target: $28
Current: $27.78
Upside: +0.79%
Aug 3, 2026
Rated: Buy
Price Target: $278 → $296
Current: $250.91
Upside: +17.97%
Aug 3, 2026
Reiterated: Buy
Price Target: $294
Current: $267.08
Upside: +10.08%
Jul 31, 2026
Reiterated: Hold
Price Target: $730 → $758
Current: $807.65
Upside: -6.15%
Jul 30, 2026
Reiterated: Hold
Price Target: $222 → $231
Current: $210.73
Upside: +9.62%
Jul 28, 2026
Rated: Buy
Price Target: $36 → $38
Current: $26.26
Upside: +44.71%
Apr 10, 2026
Reiterated: Hold
Price Target: $9
Current: $13.67
Upside: -34.16%
Feb 17, 2026
Reiterated: Sell
Price Target: $32 → $33
Current: $53.45
Upside: -38.26%
Sep 21, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.44
Upside: -
Dec 13, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.77
Upside: n/a
Jun 1, 2021
Reiterated: Sell
Price Target: $16
Current: $45.40
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $21 → $12
Current: $3.54
Upside: n/a
Aug 3, 2020
Upgraded: Buy
Price Target: €90.25
Current: €132.15
Upside: n/a
Dec 2, 2019
Initiated Coverage: Hold
Price Target: $41.51
Current: $8.50
Upside: n/a
Mar 25, 2019
Downgraded: Hold
Price Target: $18 → $16
Current: $107.04
Upside: n/a
Aug 13, 2018
Reiterated: Buy
Price Target: $163 → $155
Current: $258.00
Upside: n/a
Jun 18, 2018
Initiated Coverage: Hold
Price Target: $22
Current: $78.52
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $32 → $31
Current: $8.04
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $46
Current: $34.63
Upside: n/a
Nov 18, 2015
Rated: Hold
Price Target: $38
Current: $9.91
Upside: n/a
Jul 21, 2015
Initiated Coverage: Hold
Price Target: $36
Current: $5.28
Upside: n/a